News - Page 223 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Red Light Holland Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended September 30, 2020 and Material Change Report

Red Light Holland Announces Filing of Amended and Restated FS and MD&A for the Three and Six Month Period Ended September 30, 2020 and Material Change Report

Post published:January 14, 2021
Post category:Press Release

Read more about the article Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore

Silo Pharma Enters into Sponsored Research Agreement for Potential Multiple Sclerosis Treatment Approach with University of Maryland, Baltimore

Post published:January 13, 2021
Post category:Press Release

Read more about the article PharmaTher Approved to Trade on the OTCQB Venture Market

PharmaTher Approved to Trade on the OTCQB Venture Market

Post published:January 13, 2021
Post category:Press Release

Read more about the article Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board

Nova Mentis Appoints Dr. Julia V. Perederiy, PhD to Scientific Advisory Board

Post published:January 13, 2021
Post category:Press Release

Read more about the article Novamind Expands Psychedelic Medicine Access in Utah

Novamind Expands Psychedelic Medicine Access in Utah

Post published:January 13, 2021
Post category:Press Release

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectrometer

Post published:January 13, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Invited to Present at Global Healthcare & Psychedelic Conferences

Tryp Therapeutics Invited to Present at Global Healthcare & Psychedelic Conferences

Post published:January 13, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Engages Star Finance GmbH for Investor Relations

Entheon Biomedical Engages Star Finance GmbH for Investor Relations

Post published:January 12, 2021
Post category:Press Release

Read more about the article PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.

PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.

Post published:January 12, 2021
Post category:Press Release

Read more about the article MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers

MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers

Post published:January 12, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.